Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ORTHOPEDIATRICS CORP

Get SEC filing alerts via email and in your feed for ORTHOPEDIATRICS CORP

KIDS

ORTHOPEDIATRICS CORP

About ORTHOPEDIATRICS CORP

OrthoPediatrics Corp. specializes in designing, developing, and marketing pediatric-specific orthopedic implants, instruments, and braces for trauma, deformity correction, scoliosis, and sports medicine. Serving hospitals worldwide, it supports pediatric surgeons through dedicated sales, clinical education, and research collaborations. Its comprehensive product portfolio addresses unmet needs in children’s orthopedic care, leveraging innovation, strategic acquisitions, and a focus on improving young patients' outcomes.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ORTHOPEDIATRICS CORP

1
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports $59.4 Million Revenue in Q1 2026, Despite $10.7 Million Net Loss

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports 15% Revenue Growth to $236.3 Million for 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports $61.3M Revenue with 12% Growth, Faces $11.8M Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports $61.1 Million Revenue in Q2 2025, Faces Increased Net Loss

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports $52.4 Million Revenue in Q1 2025, Despite Increased Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports 38% Revenue Growth to $204.7 Million, Net Loss of $37.8 Million for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
ORTHOPEDIATRICS CORP OrthoPediatrics Reports 37% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments